22-38961532-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_145699.4(APOBEC3A):c.320C>T(p.Ala107Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000523 in 1,529,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000022 ( 0 hom., cov: 18)
Exomes 𝑓: 0.0000036 ( 0 hom. )
Consequence
APOBEC3A
NM_145699.4 missense
NM_145699.4 missense
Scores
2
6
10
Clinical Significance
Conservation
PhyloP100: 4.89
Genes affected
APOBEC3A (HGNC:17343): (apolipoprotein B mRNA editing enzyme catalytic subunit 3A) This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. The protein encoded by this gene lacks the zinc binding activity of other family members. The protein plays a role in immunity, by restricting transmission of foreign DNA such as viruses. One mechanism of foreign DNA restriction is deamination of foreign double-stranded DNA cytidines to uridines, which leads to DNA degradation. However, other mechanisms are also thought to be involved, as anti-viral effect is not dependent on deaminase activity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.943
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOBEC3A | NM_145699.4 | c.320C>T | p.Ala107Val | missense_variant | 3/5 | ENST00000249116.7 | NP_663745.1 | |
APOBEC3A | NM_001270406.2 | c.266C>T | p.Ala89Val | missense_variant | 3/5 | NP_001257335.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOBEC3A | ENST00000249116.7 | c.320C>T | p.Ala107Val | missense_variant | 3/5 | 1 | NM_145699.4 | ENSP00000249116.2 | ||
APOBEC3A | ENST00000402255.5 | c.320C>T | p.Ala107Val | missense_variant | 4/6 | 5 | ENSP00000384359.1 |
Frequencies
GnomAD3 genomes AF: 0.0000224 AC: 3AN: 133996Hom.: 0 Cov.: 18
GnomAD3 genomes
AF:
AC:
3
AN:
133996
Hom.:
Cov.:
18
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000419 AC: 1AN: 238768Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 128890
GnomAD3 exomes
AF:
AC:
1
AN:
238768
Hom.:
AF XY:
AC XY:
0
AN XY:
128890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000358 AC: 5AN: 1395002Hom.: 0 Cov.: 31 AF XY: 0.00000288 AC XY: 2AN XY: 694570
GnomAD4 exome
AF:
AC:
5
AN:
1395002
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
694570
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000224 AC: 3AN: 134090Hom.: 0 Cov.: 18 AF XY: 0.0000309 AC XY: 2AN XY: 64802
GnomAD4 genome
AF:
AC:
3
AN:
134090
Hom.:
Cov.:
18
AF XY:
AC XY:
2
AN XY:
64802
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.320C>T (p.A107V) alteration is located in exon 3 (coding exon 3) of the APOBEC3A gene. This alteration results from a C to T substitution at nucleotide position 320, causing the alanine (A) at amino acid position 107 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;.;T
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
PROVEAN
Uncertain
D;D;.
REVEL
Uncertain
Sift
Uncertain
D;D;.
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;D
Vest4
MutPred
Loss of methylation at R111 (P = 0.1239);Loss of methylation at R111 (P = 0.1239);Loss of methylation at R111 (P = 0.1239);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at